Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$41.99 - $62.38 $360,232 - $535,158
-8,579 Reduced 15.55%
46,576 $2.74 Million
Q3 2023

Nov 14, 2023

BUY
$27.8 - $45.35 $112,756 - $183,939
4,056 Added 7.94%
55,155 $2.4 Million
Q2 2023

Aug 21, 2023

SELL
$36.13 - $49.49 $36,780 - $50,380
-1,018 Reduced 1.95%
51,099 $1.85 Million
Q1 2023

May 09, 2023

BUY
$36.54 - $54.26 $12,715 - $18,882
348 Added 0.67%
52,117 $1.94 Million
Q4 2022

Feb 14, 2023

BUY
$41.27 - $98.62 $50,679 - $121,105
1,228 Added 2.43%
51,769 $2.35 Million
Q3 2022

Nov 18, 2022

SELL
$59.5 - $86.7 $65,688 - $95,716
-1,104 Reduced 2.14%
50,541 $3.53 Million
Q2 2022

Aug 15, 2022

BUY
$39.16 - $88.71 $19,188 - $43,467
490 Added 0.96%
51,645 $3.47 Million
Q1 2022

May 16, 2022

SELL
$75.82 - $150.97 $178,101 - $354,628
-2,349 Reduced 4.39%
51,155 $4.21 Million
Q4 2021

Feb 15, 2022

SELL
$132.01 - $190.29 $1.33 Million - $1.92 Million
-10,102 Reduced 15.88%
53,504 $7.85 Million
Q3 2021

Nov 15, 2021

SELL
$132.13 - $177.45 $1.16 Million - $1.55 Million
-8,754 Reduced 12.1%
63,606 $11.3 Million
Q2 2021

Aug 16, 2021

BUY
$144.0 - $179.73 $510,480 - $637,142
3,545 Added 5.15%
72,360 $11.7 Million
Q1 2021

May 18, 2021

SELL
$158.92 - $221.61 $31,307 - $43,657
-197 Reduced 0.29%
68,815 $11.8 Million
Q4 2020

Feb 16, 2021

BUY
$162.05 - $240.27 $1.29 Million - $1.91 Million
7,960 Added 13.04%
69,012 $15.2 Million
Q3 2020

Nov 17, 2020

BUY
$113.26 - $167.27 $626,101 - $924,668
5,528 Added 9.96%
61,052 $10.1 Million
Q2 2020

Aug 17, 2020

BUY
$72.01 - $120.39 $743,431 - $1.24 Million
10,324 Added 22.84%
55,524 $6.34 Million
Q1 2020

May 13, 2020

BUY
$69.78 - $116.21 $251,068 - $418,123
3,598 Added 8.65%
45,200 $3.48 Million
Q4 2019

Feb 14, 2020

SELL
$70.76 - $128.86 $59,509 - $108,371
-841 Reduced 1.98%
41,602 $5.36 Million
Q3 2019

Nov 15, 2019

BUY
$77.91 - $109.6 $309,614 - $435,550
3,974 Added 10.33%
42,443 $3.31 Million
Q2 2019

Aug 14, 2019

BUY
$59.49 - $104.71 $336,832 - $592,868
5,662 Added 17.26%
38,469 $3.96 Million
Q1 2019

May 09, 2019

BUY
$43.65 - $78.95 $52,903 - $95,687
1,212 Added 3.84%
32,807 $2.41 Million
Q4 2018

Feb 13, 2019

BUY
$32.0 - $47.43 $23,488 - $34,813
734 Added 2.38%
31,595 $1.34 Million
Q3 2018

Nov 14, 2018

BUY
$47.1 - $62.7 $148,035 - $197,066
3,143 Added 11.34%
30,861 $1.45 Million
Q2 2018

Aug 14, 2018

BUY
$26.05 - $52.4 $722,053 - $1.45 Million
27,718 New
27,718 $1.37 Million

Others Institutions Holding MRTX

About Mirati Therapeutics, Inc.


  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.